Cas no 1393667-83-8 (ethyl 3-chloro-1H-pyrazole-4-carboxylate)
ethyl 3-chloro-1H-pyrazole-4-carboxylate Chemical and Physical Properties
Names and Identifiers
-
- ethyl 3-chloro-1H-pyrazole-4-carboxylate
- Ethyl 5-chloro-1H-pyrazole-4-carboxylate
- Ethyl 5-chloropyrazole-4-carboxylate
- WNRMFDPBDDKWFD-UHFFFAOYSA-N
- FCH862434
- 6289AC
- ethyl-5-chloro-4-pyrazole carboxylate
- ethyl5-chloro-1H-pyrazole-4-carboxylate
- AX8221734
- AB0182564
- ST24025000
- 1H-Pyrazole-4-carboxylic
- DA-34101
- 948552-01-0
- CS-0043738
- DTXSID70646439
- AC-28849
- SY116673
- G90100
- ethyl3-chloro-1H-pyrazole-4-carboxylate
- 1393667-83-8
- 1H-Pyrazole-4-carboxylic acid, 3-chloro-, ethyl ester
- MFCD28050408
- AKOS006291019
- Y10509
- MFCD08689931
- SCHEMBL23824155
- DS-17777
- SCHEMBL20303941
-
- MDL: MFCD08689931
- Inchi: 1S/C6H7ClN2O2/c1-2-11-6(10)4-3-8-9-5(4)7/h3H,2H2,1H3,(H,8,9)
- InChI Key: WNRMFDPBDDKWFD-UHFFFAOYSA-N
- SMILES: ClC1=C(C=NN1)C(=O)OCC
Computed Properties
- Exact Mass: 174.0196052g/mol
- Monoisotopic Mass: 174.0196052g/mol
- Isotope Atom Count: 0
- Hydrogen Bond Donor Count: 1
- Hydrogen Bond Acceptor Count: 3
- Heavy Atom Count: 11
- Rotatable Bond Count: 3
- Complexity: 154
- Covalently-Bonded Unit Count: 1
- Defined Atom Stereocenter Count: 0
- Undefined Atom Stereocenter Count : 0
- Defined Bond Stereocenter Count: 0
- Undefined Bond Stereocenter Count: 0
- Topological Polar Surface Area: 55
- XLogP3: 1.4
Experimental Properties
- Boiling Point: 322.9±34.0°C at 760 mmHg
ethyl 3-chloro-1H-pyrazole-4-carboxylate Security Information
- Signal Word:Warning
- Hazard Statement: H302-H315-H319-H335
- Warning Statement: P261-P305+P351+P338
- Storage Condition:Inert atmosphere,2-8°C(BD221734)??? Inert atmosphere,2-8°C(BD297690)
ethyl 3-chloro-1H-pyrazole-4-carboxylate Pricemore >>
| Related Categories | No. | Product Name | Cas No. | Purity | Specification | Price | update time | Inquiry |
|---|---|---|---|---|---|---|---|---|
| abcr | AB439087-250 mg |
Ethyl 5-chloro-1H-pyrazole-4-carboxylate, 95%; . |
1393667-83-8 | 95% | 250MG |
€115.70 | 2022-03-02 | |
| abcr | AB439087-1 g |
Ethyl 5-chloro-1H-pyrazole-4-carboxylate, 95%; . |
1393667-83-8 | 95% | 1g |
€233.60 | 2022-03-02 | |
| abcr | AB439087-5 g |
Ethyl 5-chloro-1H-pyrazole-4-carboxylate, 95%; . |
1393667-83-8 | 95% | 5g |
€762.90 | 2022-03-02 | |
| Fluorochem | 220480-1g |
Ethyl 5-chloro-1H-pyrazole-4-carboxylate |
1393667-83-8 | 95% | 1g |
£96.00 | 2022-02-28 | |
| Fluorochem | 220480-5g |
Ethyl 5-chloro-1H-pyrazole-4-carboxylate |
1393667-83-8 | 95% | 5g |
£380.00 | 2022-02-28 | |
| Chemenu | CM249246-250mg |
Ethyl 5-chloro-1H-pyrazole-4-carboxylate |
1393667-83-8 | 95+% | 250mg |
$61 | 2021-08-04 | |
| Chemenu | CM249246-1g |
Ethyl 5-chloro-1H-pyrazole-4-carboxylate |
1393667-83-8 | 95+% | 1g |
$193 | 2021-08-04 | |
| Chemenu | CM249246-5g |
Ethyl 5-chloro-1H-pyrazole-4-carboxylate |
1393667-83-8 | 95+% | 5g |
$709 | 2021-08-04 | |
| Chemenu | CM249246-10g |
Ethyl 5-chloro-1H-pyrazole-4-carboxylate |
1393667-83-8 | 95+% | 10g |
$1205 | 2021-08-04 | |
| TRC | E927310-10mg |
Ethyl 5-chloro-1H-pyrazole-4-carboxylate |
1393667-83-8 | 10mg |
$ 50.00 | 2022-06-05 |
ethyl 3-chloro-1H-pyrazole-4-carboxylate Related Literature
-
Huiying Xu,Lu Zheng,Yu Zhou,Bang-Ce Ye Analyst, 2021,146, 5542-5549
-
Priyambada Nayak,Tanmaya Badapanda,Anil Kumar Singh,Simanchalo Panigrahi RSC Adv., 2017,7, 16319-16331
-
Siquan Zhang,Shengyao Wang,Liping Guo,Hao Chen,Bien Tan,Shangbin Jin J. Mater. Chem. C, 2020,8, 192-200
-
Jialiang Yuan,Ran Dong,Yuan Li,Yang Liu,Zhuo Zheng,Yuxia Liu,Yan Sun,Benhe Zhong,Zhenguo Wu,Xiaodong Guo Chem. Commun., 2021,57, 13004-13007
Additional information on ethyl 3-chloro-1H-pyrazole-4-carboxylate
Introduction to Ethyl 3-chloro-1H-pyrazole-4-carboxylate (CAS No. 1393667-83-8)
Ethyl 3-chloro-1H-pyrazole-4-carboxylate (CAS No. 1393667-83-8) is a significant compound in the field of pharmaceutical chemistry, playing a crucial role in the synthesis of various bioactive molecules. This compound, characterized by its pyrazole core structure, has garnered considerable attention due to its versatile applications in drug development and medicinal chemistry.
The molecular structure of ethyl 3-chloro-1H-pyrazole-4-carboxylate consists of a pyrazole ring substituted with a chloro group at the 3-position and a carboxylate ester at the 4-position. This unique arrangement provides multiple sites for chemical modification, making it a valuable intermediate in the synthesis of more complex molecules. The presence of the chloro group enhances its reactivity, allowing for further functionalization through nucleophilic substitution reactions.
In recent years, there has been growing interest in the development of novel heterocyclic compounds for their potential therapeutic applications. Pyrazole derivatives, in particular, have shown promise in various pharmacological contexts, including antimicrobial, anti-inflammatory, and anticancer activities. The compound ethyl 3-chloro-1H-pyrazole-4-carboxylate is no exception and has been explored in several research studies for its pharmacological properties.
One of the most notable applications of ethyl 3-chloro-1H-pyrazole-4-carboxylate is in the synthesis of kinase inhibitors. Kinases are enzymes that play a critical role in cell signaling pathways and are often targeted in the development of anti-cancer therapies. Researchers have utilized this compound as a building block to create novel inhibitors that can modulate kinase activity. For instance, studies have demonstrated its use in developing inhibitors targeting tyrosine kinases, which are implicated in various cancers.
The versatility of ethyl 3-chloro-1H-pyrazole-4-carboxylate extends to its role in the synthesis of non-peptide agonists and antagonists. These compounds are essential in drug development as they can interact with biological targets without the need for peptide sequences. The pyrazole core provides a scaffold that can be modified to enhance binding affinity and selectivity. Recent research has highlighted its use in developing ligands for G protein-coupled receptors (GPCRs), which are involved in numerous physiological processes and are common targets for therapeutic intervention.
In addition to its applications in oncology and neurology, ethyl 3-chloro-1H-pyrazole-4-carboxylate has been explored for its potential antimicrobial properties. The chloro-substituted pyrazole ring contributes to its ability to interact with bacterial enzymes and disrupt essential metabolic pathways. Studies have shown promising results when this compound is used in combination with other agents to combat drug-resistant bacteria. This approach is particularly relevant given the increasing challenge posed by antibiotic-resistant pathogens.
The synthetic utility of ethyl 3-chloro-1H-pyrazole-4-carboxylate is further underscored by its role as a precursor in the preparation of more complex heterocyclic systems. For example, it can be used to synthesize pyrazolopyrimidines and pyrazolothiazines, which are known for their diverse biological activities. These derivatives have been investigated for their potential use as antiviral agents, particularly against RNA viruses such as influenza and HIV.
The chemical reactivity of the chloro group in ethyl 3-chloro-1H-pyrazole-4-carboxylate allows for further functionalization through cross-coupling reactions such as Suzuki-Miyaura and Buchwald-Hartwig couplings. These reactions are powerful tools for constructing carbon-carbon bonds and have been widely used in organic synthesis. By incorporating this compound into synthetic strategies, chemists can access a wide range of functionalized pyrazole derivatives with tailored properties.
The pharmaceutical industry continues to invest heavily in the discovery and development of novel heterocyclic compounds due to their broad spectrum of biological activities. Ethyl 3-chloro-1H-pyrazole-4-carboxylate stands out as a versatile intermediate that has found applications across multiple therapeutic areas. Its role in synthesizing kinase inhibitors, GPCR ligands, and antimicrobial agents underscores its importance in modern drug discovery.
1393667-83-8 (ethyl 3-chloro-1H-pyrazole-4-carboxylate) Related Products
- 34127-22-5(Ethyl 3,6-dichloropyridazine-4-carboxylate)
- 148934-66-1(Methyl 3-chloro-1-methyl-1H-pyrazole-4-carboxylate)
- 134589-59-6(3-Chloro-1H-pyrazole-4-carboxylic acid)
- 2091712-01-3(Ethyl 3,6-dichloro-5-methylpyridazine-4-carboxylate)
- 948552-01-0(Ethyl 5-chloro-1H-pyrazole-4-carboxylate)
- 1445-54-1(Ethyl 3-chloropyridazine-4-carboxylate)
- 118197-42-5(ethyl 3-chloro-1-methyl-1H-pyrazole-4-carboxylate)
- 56984-32-8(Ethyl 5-Chloro-1-methyl-1H-pyrazole-4-carboxylate)
- 2089301-64-2(Methyl 3-chloro-1H-pyrazole-4-carboxylate)
- 1186049-67-1(5-Chloro-1H-pyrazole-4-carboxylic acid)